Author Archives: Scalper1

Which Stocks Are Dodging Most Of The Damage?

Top industry groups struggled Monday. The day’s best groups kept their losses much smaller than the indexes. When the market is losing in chunks, small losses sound good. Top-rated groups holding up best were mostly in the bank and savings and loans sectors. If rates rise, bank margins should improve. Beverages, both alcoholic and soft, also held up pretty well. Education and media software played good defense, too. Individual investors might

Despite EU OK, Regeneron Crumbles Below 200-Day

Biotechs and drugmaker stocks are leading today’s losses, and Regeneron Pharmaceuticals (REGN) is showing particular weakness. Despite announcing European Commission marketing approval for its cholesterol drug Praluent, the biotech’s shares are crumbling. The stock was down 8% in afternoon trade. Volume was heavy. The move is a substantial blow to shares, which are now trading below the 200-day line for the first time in more than a year.